Erythropoietin and Non-Erythropoietic Derivatives in Cognition.
Erythropoietin and Non-Erythropoietic Derivatives in Cognition.
复制标题
DOI:
10.3389/fphar.2021.728725
复制
发表时间:
2021
影响因子:
5.6
通讯作者:
Sathyanesan M
中科院分区:
文献类型:
--
作者:
Newton SS;Sathyanesan M
Cognitive deficits are widespread in psychiatric disorders, including major depression and schizophrenia. These deficits are known to contribute significantly to the accompanying functional impairment. Progress in the development of targeted treatments of cognitive deficits has been limited and there exists a major unmet need to develop more efficacious treatments. Erythropoietin (Epo) has shown promising procognitive effects in psychiatric disorders, providing support for a neurotrophic drug development approach. Several preclinical studies with non-erythropoietic derivatives have demonstrated that the modulation of behavior is independent of erythropoiesis. In this review, we examine the molecular, cellular and cognitive actions of Epo and non-erythropoietic molecular derivatives by focusing on their neurotrophic, synaptic, myelin plasticity, anti-inflammatory and neurogenic mechanisms in the brain. We also discuss the role of receptor signaling in Epo and non-erythropoietic EPO-mimetic molecules in their procognitive effects.
登录
查看更多内容
DOI:
10.1093/ijnp/pyx070
发表时间:
2018-02-01
期刊:
The international journal of neuropsychopharmacology
影响因子:
--
作者:
Baune BT;Brignone M;Larsen KG
通讯作者:
Larsen KG
影响因子:
11
作者:
Ehrenreich, H.;Hinze-Selch, D.;Krampe, H.
通讯作者:
Krampe, H.
影响因子:
5.1
作者:
Gao, Rong;Tang, Yuan-hui;Zhu, Si-hai
通讯作者:
Zhu, Si-hai
影响因子:
2.9
作者:
Agnello, D;Bigini, P;Ghezzi, P
通讯作者:
Ghezzi, P
影响因子:
11
作者:
Butt UJ;Steixner-Kumar AA;Depp C;Sun T;Hassouna I;Wüstefeld L;Arinrad S;Zillmann MR;Schopf N;Fernandez Garcia-Agudo L;Mohrmann L;Bode U;Ronnenberg A;Hindermann M;Goebbels S;Bonn S;Katschinski DM;Miskowiak KW;Nave KA;Ehrenreich H
通讯作者:
Ehrenreich H